| SC 13G/A | 2017-02-14 | Flynn James E | EndoChoice Holdings, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | SC US GF V Holdings, Ltd. | EndoChoice Holdings, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-02 | ENVEST III LLC | EndoChoice Holdings, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2016-12-21 | U.M. AccelMed, Limited Partnership | EndoChoice Holdings, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2016-11-28 | GAMCO INVESTORS, INC. ET AL | EndoChoice Holdings, Inc. | - | 0.0% | EDGAR |
| SC 13D | 2016-10-20 | GAMCO INVESTORS, INC. ET AL | EndoChoice Holdings, Inc. | 867,520 | 3.4% | EDGAR |
| SC 13G/A | 2016-10-11 | WELLINGTON MANAGEMENT GROUP LLP | EndoChoice Holdings, Inc. | 923,884 | 3.6% | EDGAR |
| SC 13G/A | 2016-08-09 | WELLINGTON MANAGEMENT GROUP LLP | EndoChoice Holdings, Inc. | 2,755,921 | 10.6% | EDGAR |
| SC 13G | 2016-02-24 | River Cities Capital Fund IV, L.P. | EndoChoice Holdings, Inc. | 2,173,827 | 8.8% | EDGAR |
| SC 13G | 2016-02-19 | Council Capital II, L.P. | EndoChoice Holdings, Inc. | 1,521,238 | 6.1% | EDGAR |
| SC 13G/A | 2016-02-16 | ENVEST III LLC | EndoChoice Holdings, Inc. | 1,771,059 | 7.1% | EDGAR |
| SC 13G/A | 2016-02-16 | Flynn James E | EndoChoice Holdings, Inc. | 624,359 | 2.5% | EDGAR |
| SC 13G | 2016-02-12 | SC US GF V Holdings, Ltd. | EndoChoice Holdings, Inc. | 2,188,962 | 8.8% | EDGAR |
| SC 13G | 2016-02-11 | WELLINGTON MANAGEMENT GROUP LLP | EndoChoice Holdings, Inc. | 2,246,648 | 9.1% | EDGAR |
| SC 13G/A | 2015-06-24 | Flynn James E | EndoChoice Holdings, Inc. | 598,759 | 2.4% | EDGAR |
| SC 13G | 2015-06-22 | Flynn James E | EndoChoice Holdings, Inc. | 598,759 | 2.4% | EDGAR |
| SC 13D | 2015-06-15 | U.M. AccelMed, Limited Partnership | EndoChoice Holdings, Inc. | 2,284,989 | 9.1% | EDGAR |